FindTrial
Sign In

Effect of dexmedetomidine on clinical outcomes in critically ill patients

A pilot study for association of infusion rate of dexmedetomidine in critically ill patients with hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006355
Enrollment
300
Registered
2021-07-20
Start date
2020-07-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Catholic Kwandong University International St.Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Among adult patients aged 18 or older who were hospitalized in surgical and medical intensive care unit at Catholic Kwandong University International St. Mary's Hospital from January 1, 2019 to December 31, 2019 and patients who were given Dexmedetomidine more than twice during their hospitalization.

Exclusion criteria

Exclusion criteria: 1) Patients who admitted in intensive care unit less than 48 hours 2) Lack of information of dexmedetomidine infusion rate, dose, or related fluids

Design outcomes

Primary

MeasureTime frame
The mean intravenous infusion rate of dexmedetomidine;Length of intensive care unit stay—

Secondary

MeasureTime frame
Length of hospital stay;Mortality;Adverse drug event—

Countries

Korea, Republic of

Contacts

Public ContactJee Yun Kim

Catholic Kwandong University International St.Mary's Hospital

parallelspac@naver.com+82-32-290-3450

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026